2009
DOI: 10.1002/ar.20874
|View full text |Cite
|
Sign up to set email alerts
|

A Potential Role of Collagens Expression in Distinguishing Between Premalignant and Malignant Lesions in Stomach

Abstract: Lack of clinical biomarkers for early gastric cancer without specific early symptoms leads to delayed diagnosis, which contributes to high mortality of gastric cancer. Here, we used oligonucleotide microarray to systematically examine differential gene expression among 33 samples from normal, premalignant, and malignant lesions in stomach. A focal adhesion pathway mainly composed of collagen genes was found to have a significantly different expression profile in gastric cancers compared to premalignant lesions… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
41
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(47 citation statements)
references
References 28 publications
4
41
0
1
Order By: Relevance
“…Epidermal activation of bcatenin led to the upregulation of a small subset of matrix genes including Col11a1, a prognostic marker of malignant stomach lesions (Zhao et al, 2009) and of colorectal cancers (Suceveanu et al, 2009). We speculate that the stroma of human sebaceous gland tumours bearing LEF1 mutations that inhibit Wnt signalling (Takeda et al, 2006) will have different characteristics to the stroma of pilomatricomas with activating b-catenin mutations (Chan et al, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…Epidermal activation of bcatenin led to the upregulation of a small subset of matrix genes including Col11a1, a prognostic marker of malignant stomach lesions (Zhao et al, 2009) and of colorectal cancers (Suceveanu et al, 2009). We speculate that the stroma of human sebaceous gland tumours bearing LEF1 mutations that inhibit Wnt signalling (Takeda et al, 2006) will have different characteristics to the stroma of pilomatricomas with activating b-catenin mutations (Chan et al, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…In transitional cell carcinoma of the bladder, colXIα1 is one of seven genes with differential expression between superficial and muscle-invasive tumors 45 . ColXIα1 expression is also capable of differentiating premalignant from malignant stomach cancers 46 . See Table 1 for a summary of colXIα1 dysregulation across cancer types.…”
Section: Dysregulation Of Collagen Xiα1 In Cancermentioning
confidence: 99%
“…miR-29a targets collagens COL3A1, COL11A1, CO-L4A5, and COL4A4, and Fibrillin1 (FBN1), which participate in integrin signaling, focal adhesion and migration. In gastric cancer, transcripts for several collagens, including COLA11A1, are also up-regulated in malignant compared to pre-malignant tumors 28 and COLA11A1 is also up-regulated in cancer-associated fibroblasts of colon adenocarcinomas. 29 Insulin-like Growth Factor 1 (IGF1) is a key player in NSCLC tumorigenesis and metastasis, 30 initiating cell signaling, promoting mitosis, proliferation and differentiation, and inhibiting apoptosis.…”
Section: Discussionmentioning
confidence: 99%